A Systems Biology Consideration of the Vasculopathy of Sickle Cell Anemia: The Need for Multi-Modality Chemo-Prophylaxis
- 1 December 2009
- journal article
- Published by Bentham Science Publishers Ltd. in Cardiovascular & Hematological Disorders-Drug Targets
- Vol. 9 (4) , 271-292
Abstract
Much of the morbidity and mortality of sickle cell anemia is accounted for by a chronic vasculopathy syndrome. There is currently no identified therapy, interventional or prophylactic, for this problem. For two reasons, development of an effective therapeutic approach will require a systems biology level perspective on the vascular pathobiology of sickle disease. In the first place, multiple biological processes contribute to the pathogenesis of vasculopathy: red cell sickling, inflammation and adhesion biology, coagulation activation, stasis, deficient bioavailability and excessive consumption of NO, excessive oxidation, and reperfusion injury physiology. The probable hierarchy of involvement of these disparate sub-biologies places inflammation caused by reperfusion injury physiology as the likely, proximate, linking pathophysiological factor. In the second place, most of these sub-biologies overlap with each other and, in any case, have multiple points of potential interaction and transactivation. Consequently, an approach modeled upon chemotherapy for cancer is needed. This would be a truly multi-modality approach that hopefully could be achieved via employment of relatively few drugs. It is proposed here that the specific combination of a statin with suberoylanilide hydroxamic acid would provide a suitable, broad, multi-modality approach to chemo-prophylaxis for sickle vasculopathy.Keywords
This publication has 116 references indexed in Scilit:
- Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stressAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell diseaseBlood, 2008
- Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell diseaseJournal of Clinical Investigation, 2008
- Genetic endothelial systems biology of sickle stroke riskBlood, 2008
- Redox-dependent impairment of vascular function in sickle cell diseaseFree Radical Biology and Medicine, 2007
- A network model to predict the risk of death in sickle cell diseaseBlood, 2007
- Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypesBlood Reviews, 2007
- Protective effect of arginine on oxidative stress in transgenic sickle mouse modelsFree Radical Biology and Medicine, 2006
- Inflammation in atherosclerosisNature, 2002
- Origins of circulating endothelial cells and endothelial outgrowth from bloodJournal of Clinical Investigation, 2000